This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (861)
Death (127)
Life Threatening Events (36)
Disability (5)
Reports by Reaction Type
Febrile Neutropenia (100),
Neutropenia (83),
Drug Ineffective (68),
Dyspnoea (65),
Pyrexia (63),
Bone Pain (56),
Fatigue (56),
Anaemia (44),
Chest Pain (39),
Nausea (39),
Diarrhoea (39),
Back Pain (37)
Below are a few examples of reports where side effects / adverse reactions may be related to Neulasta (Pegfilgrastim). For a complete list or a specific selection of reports, please use the links above.
Possible Neulasta side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-27
Patient: 47 year old female
Reactions: Bone Pain, Musculoskeletal Disorder
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents; Acetaminophen; Metoclopramide; Dexamethasone; Emend; Ciprofloxacin HCL
Possible Neulasta side effects in 62 year old female
Reported by a physician from Finland on 2012-08-27
Patient: 62 year old female
Reactions: Back Pain, Dysphagia, Stomatitis, Dyspnoea, Pain in Extremity, Hypotension, Bone Pain, Constipation, Abdominal Pain Upper, Joint Stiffness, Myalgia, Malaise, Insomnia, Oedema Peripheral, Musculoskeletal Stiffness, Gait Disturbance, Candidiasis
Drug(s) suspected as cause:
Docetaxel
Dosage: 80 mg/m2, unk
Indication: Metastasis
Start date: 2012-04-26
End date: 2012-04-28
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2012-04-28
End date: 2012-06-11
Neupogen
Dosage: unk
Indication: Chemotherapy
Start date: 2012-07-21
End date: 2012-07-27
Possible Neulasta side effects in female
Reported by a physician from Germany on 2012-08-27
Patient: female
Reactions: Drug Ineffective, Lymphopenia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Doxorubicin Hydrochloride; Prednisone TAB; Rituximab; Vincristine; Cyclophosphamide
Possible Neulasta side effects in 28 year old female
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: 28 year old female, weighing 77.1 kg (169.6 pounds)
Reactions: Breast Cancer, Drug Ineffective, Nausea, Bone Pain, Headache, Anxiety, Pneumothorax, Depression, Eye Pruritus
Drug(s) suspected as cause:
Neulasta
Indication: White Blood Cell Count Decreased
Start date: 2012-07-01
Nexium
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
Start date: 2012-07-01
Prilosec
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
Start date: 2002-01-01
End date: 2012-07-01
Steroid Therapy
Other drugs received by patient: Dexamethasone; Kytril; Promethazine; IV Fluids; Sertraline Hydrochloride; Marinol; Xanax; Singulair; Allegra; Hydrocodone Acetominophen; Fioricet
Possible Neulasta side effects in female
Reported by a pharmacist from Canada on 2012-08-27
Patient: female
Reactions: Intestinal Perforation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cyclophosphamide; Doxorubicin Hydrochloride
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Doxorubicin Hydrochloride
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Other drugs received by patient: MST / 00036302 /; Novalgin / 00169801 /; Rulid; Pantoprazole; Paspertin / 00041902 /; Acyclovir; Electrolytes NOS W / Macrogol 3350; Dipyrone INJ; Metoclopramide; Acyclovir
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: female, weighing 87.7 kg (192.9 pounds)
Reactions: Anxiety, Chest Pain, Stress
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: every 2 weeks x 3 cycles
Start date: 2012-07-12
End date: 2012-08-09
Gemcitabine Hydrochloride
Dosage: every 2 weeks x 3 cycles
Start date: 2012-07-12
End date: 2012-08-09
Neulasta
Dosage: day 2 of cycle x 3
Start date: 2012-07-08
End date: 2012-08-11
Possible Neulasta side effects in 47 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-23
Patient: 47 year old female
Reactions: Abdominal Pain, Bone Pain, Neutropenia, Muscle Spasms
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Cyclophosphamide; Docetaxel
Possible Neulasta side effects in 50 year old female
Reported by a pharmacist from United Kingdom on 2012-08-23
Patient: 50 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents; Ciprofloxacin
Possible Neulasta side effects in 50 year old female
Reported by a physician from United Kingdom on 2012-08-23
Patient: 50 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: Swelling Face, Dyspnoea, Body Temperature Increased, Drug Ineffective, Neutropenic Sepsis, Anaphylactic Reaction, Swollen Tongue, Erythema, Oedema Mucosal, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Fluorouracil; Dexamethasone; Zofran; Metoclopramide; Epirubicin; Cyclophosphamide
Possible Neulasta side effects in 44 year old female
Reported by a physician from Germany on 2012-08-23
Patient: 44 year old female, weighing 72.0 kg (158.4 pounds)
Reactions: Venous Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1110 mg, q3wk
Indication: Breast Cancer
Start date: 2010-08-03
End date: 2010-10-05
Neulasta
Dosage: 6 mg, qd
Indication: Colony Stimulating Factor Prophylaxis
Start date: 2010-10-06
Taxotere
Dosage: 138.75 mg, q3wk
Indication: Breast Cancer
Start date: 2010-08-03
End date: 2010-10-05
Other drugs received by patient: Dexamethasone Sodium Phosphate; Dexamethasone Sodium Phosphate; Palonosetron; Mesna; Bromocriptin; Dexamethasone Sodium Phosphate; Mesna
Possible Neulasta side effects in 16 year old male
Reported by a pharmacist from Australia on 2012-08-22
Patient: 16 year old male
Reactions: LIP Swelling, Swelling Face, Anaphylactic Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Doxorubicin HCL; Vinblastine Sulfate; Dacarbazine; Bleomycin
Possible Neulasta side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22
Patient: 67 year old female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Ebastine
Dosage: 10 mg, unk
Indication: Faecaloma
Ebastine
Indication: Pruritus
Halaven
Dosage: unk
Indication: Faecaloma
Start date: 2012-06-19
Halaven
Dosage: 1.58 mg, unk
Indication: Pruritus
Start date: 2012-06-26
Loratadine
Indication: Pruritus
Loratadine
Indication: Faecaloma
Neulasta
Indication: Pruritus
Neulasta
Dosage: unk
Indication: Faecaloma
Solu-Medrol
Dosage: 20 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Solu-Medrol
Indication: Pruritus
Zantac
Indication: Pruritus
Zantac
Dosage: 50 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Zofran
Dosage: 8 mg, unk
Indication: Faecaloma
Start date: 2012-06-26
Zofran
Indication: Pruritus
Other drugs received by patient: Acebutolol; Nexium
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-22
Patient: female
Reactions: Death, Drug Ineffective, Pseudomonas Infection, Pancytopenia, Neutropenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Etoposide; Topotecan Hydrochloride; Cisplatin
Possible Neulasta side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female
Reactions: Visual Impairment, Dizziness, Asthenia, Bladder Cancer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Antineoplastic Agents
Possible Neulasta side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in female
Reported by a physician from Denmark on 2012-08-21
Patient: female, weighing 74.0 kg (162.8 pounds)
Reactions: Back Pain, Pulmonary Embolism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Cyclophosphamide
Dosage: 05/mar/2012: last dose prioe to onset of sae
Start date: 2012-03-05
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Doxorubicin HCL
Start date: 2012-03-05
Mabthera
Dosage: last dose prior to sae was on 13/feb/2012
Start date: 2012-03-05
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Mabthera
Start date: 2012-02-13
Neulasta
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-10
End date: 2012-02-10
Neulasta
Start date: 2012-02-23
Neulasta
Start date: 2012-03-08
Prednisone TAB
Dosage: last dose prior to sae was on 9/mar/2012
Administration route: Oral
Start date: 2012-03-05
Prednisone TAB
Administration route: Oral
Start date: 2012-02-27
End date: 2012-02-27
Prednisone TAB
Administration route: Oral
Start date: 2012-02-20
End date: 2012-02-24
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Vincristine
Start date: 2012-03-05
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-02-07
Other drugs received by patient: Acyclovir; Ondansetron; Tramadol HCL; Lansoprazole; Acyclovir; Lansoprazole; Bactrim
Possible Neulasta side effects in 22 year old female
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: 22 year old female
Reactions: Dysphagia, Pain, Bone Pain, Oropharyngeal Pain, Pharyngeal Oedema, Swelling, Dysuria, Heart Rate Increased
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Dacarbazine; Tylenol PM; Motrin; Claritin / 00917501 /; Adriamycin PFS; Tylenol (Caplet); Bleomycin; Reclipsen; Vinblastine Sulfate
Possible Neulasta side effects in 45 year old female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-21
Patient: 45 year old female
Reactions: Ear Pain, Muscular Weakness, Local Swelling, Headache, Sense of Oppression, Pain in JAW
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, q3wk
Indication: Chemotherapy
Start date: 2012-07-25
Prolia
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide; Ciprofloxacin; Diclofenac; Aprepitant; Metamucil / 00029101 /; Dexamethasone; Pantoprazole; Calci Chew D3; Antineoplastic Agents
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from France on 2012-08-21
Patient: female
Reactions: Fatigue, Nausea, Herpes Zoster
Drug(s) suspected as cause:
Ebsatine
Indication: Faecaloma
Ebsatine
Indication: Pruritus
Halaven
Dosage: 1.58 mg/day
Start date: 2012-06-26
Halaven
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-19
Loratadine
Indication: Pruritus
Loratadine
Indication: Faecaloma
Neulasta
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Solu-Medrol
Dosage: 20 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zantac
Dosage: 50 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zofran
Dosage: 8 mg/day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Acebutolol; Nexium
Possible Neulasta side effects in female
Reported by a physician from Germany on 2012-08-20
Patient: female
Reactions: Drug Ineffective, Lymphopenia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Doxorubicin HCL; Rituximab; Prednisone TAB; Cyclophosphamide; Vincristine
Possible Neulasta side effects in 77 year old female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-20
Patient: 77 year old female, weighing 85.0 kg (187.0 pounds)
Reactions: Myalgia, Dyspnoea, Malaise, Palpitations, Sepsis, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Docetaxel; Doxorubicin Hydrochloride
Possible Neulasta side effects in 18 year old
Reported by a physician from Germany on 2012-08-17
Patient: 18 year old
Reactions: Abdominal Discomfort
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 35 mg/m2, unk
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: 10 mg/m2, unk
Indication: Hodgkin's Disease
Cotrim
Cyclophosphamide
Dosage: 1250 mg/m2, unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 200 mg/m2, unk
Indication: Hodgkin's Disease
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2011-10-15
Prednisone TAB
Dosage: 40 mg/m2, unk
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, unk
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, unk
Indication: Hodgkin's Disease
Possible Neulasta side effects in 63 year old male
Reported by a consumer/non-health professional from United States on 2012-08-17
Patient: 63 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: female
Reactions: Malaise, Chest Discomfort, Feeling Hot, Erythema
Drug(s) suspected as cause:
Neulasta
Dosage: unk
Indication: Chemotherapy
Neupogen
Dosage: unk
Indication: Chemotherapy
Possible Neulasta side effects in 49 year old male
Reported by a physician from United States on 2012-08-16
Patient: 49 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Burning Sensation, Nausea, Arthralgia, Oedema Peripheral
Drug(s) suspected as cause:
Aranesp
Dosage: unk
Indication: Anaemia of Malignant Disease
Start date: 2011-08-13
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2011-08-13
Neupogen
Dosage: unk
Indication: Chemotherapy
Start date: 2011-08-15
Nplate
Dosage: 500 mug, prn
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2011-08-15
Other drugs received by patient: Gemzar; Oxycodone; Bactroban; Ondansetron; Oxaliplatin; Nystatin; Remeron; Melatonin; Restoril; Aldactone
Possible Neulasta side effects in 39 year old
Reported by a physician from Germany on 2012-08-16
Patient: 39 year old
Reactions: Angina Pectoris, Bone Pain, Chest Pain, Febrile Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Bleomycin Sulfate; Diazepam; Adriamycin PFS; Procarbazine Hydrochloride; Emend; Vincristine; Etoposide; Prednisone TAB; Mesna; Levofloxacin; Cyclophosphamide; Emend
Possible Neulasta side effects in 45 year old female
Reported by a physician from Canada on 2012-08-16
Patient: 45 year old female, weighing 61.0 kg (134.2 pounds)
Reactions: Migraine
Drug(s) suspected as cause:
Neulasta
Dosage: 10 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2011-05-24
Neupogen
Dosage: unk mg, unk
Indication: Product Used FOR Unknown Indication
Possible Neulasta side effects in 82 year old female
Reported by a consumer/non-health professional from United States on 2012-08-16
Patient: 82 year old female
Reactions: Urticaria, Neutropenia, Rash
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, q3wk
Indication: Breast Cancer
Start date: 2012-01-04
End date: 2012-02-01
Neupogen
Indication: Breast Cancer
Start date: 2012-03-08
Other drugs received by patient: Dexamethasone; Cytoxan; Enalapril Maleate; Metoprolol Tartrate; Taxotere
Possible Neulasta side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient:
Reactions: Injection Site Erythema
Drug(s) suspected as cause:
Neulasta
Dosage: unk
Indication: Product Used FOR Unknown Indication
Neupogen
Dosage: unk
Indication: Product Used FOR Unknown Indication
|